Which company develops and produces capmatinib?

Capmatinib is a targeted therapy drug developed and produced by Novartis Pharmaceuticals. Novartis is a leading global pharmaceutical company dedicated to the research and development of innovative drugs to meet the treatment needs of patients around the world for a variety of diseases.

This drug is mainly used to treat patients with overexpression or gene mutations of MET (tyrosine kinase) in non-small cell lung cancer (NSCLC). MET is a protein that is involved in regulating cell growth, differentiation and migration. In some cancers, the MET pathway may be abnormal, leading to abnormal growth and spread of cancer cells. Capmatinib inhibits the development of lung cancer by inhibiting the activity of MET kinase and specifically interfering with the growth signaling of cancer cells.

As a targeted therapy, capmatinib represents an advancement in personalized medicine and provides a new, targeted treatment option for some lung cancer patients. The drug has already achieved positive results in the treatment of some non-small cell lung cancer, bringing patients better survival and quality of life.

Patients should follow their doctor's advice when using capmatinib and receive regular medical monitoring during treatment to ensure the efficacy and safety of the drug. This novel treatment option provides more hope for lung cancer patients and demonstrates the pharmaceutical industry’s continued efforts in the field of cancer treatment.

Capmatinib is not yet available in China, so patients cannot purchase it domestically yet and need to purchase it through overseas channels. Currently, there are Hong Kong version of original drugs and foreign original drugs and generic drugs. The price of Hong Kong version of original drugs is about 35,000 yuan. The overseas original drugs are mainly European version of original drugs, and the price is more than 50,000 yuan, so original drugs are still relatively expensive. Generic drugs on the market abroad are much cheaper, mainly Laos generic drugs, the price is around 3,000 to 4,000 yuan, and the ingredients of original drugs and generic drugs are basically the same.